{"id":1905,"date":"2008-03-01T12:04:00","date_gmt":"2008-03-01T11:04:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/strontiumranelat-zur-therapie-der-osteoporose"},"modified":"2022-03-17T14:11:22","modified_gmt":"2022-03-17T13:11:22","slug":"strontiumranelat-zur-therapie-der-osteoporose","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2008\/strontiumranelat-zur-therapie-der-osteoporose","title":{"rendered":"Strontiumranelat zur Therapie der Osteoporose"},"content":{"rendered":"<p>In einem Cochrane-Review wurde der Effekt von Strontiumranelat zur Pr\u00e4vention der postmenopausalen Osteoporose au\u00dferordentlich positiv bewertet (1). Laut Cochrane konnten in drei Studien mit 5254 Frauen durch die t\u00e4gliche Einnahme von 2 g Strontiumranelat \u00fcber drei Jahre Wirbelfrakturen zu 37% verhindert werden (RR: 0,63; 95%-Konfidenzintervall = CI: 0,56-0,71). In zwei Studien mit 6572 Frauen (2 [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In einem Cochrane-Review wurde der Effekt von Strontiumranelat zur Pr\u00e4vention der postmenopausalen Osteoporose au\u00dferordentlich positiv bewertet (1). Laut Cochrane konnten in drei Studien mit 5254 Frauen durch die t\u00e4gliche Einnahme von 2 g Strontiumranelat \u00fcber drei Jahre Wirbelfrakturen zu 37% verhindert werden (RR: 0,63; 95%-Konfidenzintervall = CI: 0,56-0,71). In zwei Studien mit 6572 Frauen (2 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[70,4132,1346,4131],"class_list":["post-1905","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-osteoporose","tag-soti-studie","tag-strontiumranelat","tag-tropos-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1905"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1905\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1905"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1905"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}